Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1-(4-methoxybenzoyl)-2-pyrrolidinone
2. 1-anisoyl-2-pyrrolidinone
3. Ro 13-5057
4. Ro-13-5057
1. 72432-10-1
2. Draganon
3. Sarpul
4. 1-(4-methoxybenzoyl)pyrrolidin-2-one
5. 1-(4-methoxybenzoyl)-2-pyrrolidinone
6. Ampamet
7. Ro 13-5057
8. 1-p-anisoyl-2-pyrrolidinone
9. Ro-13-5057
10. 1-p-anisoylpyrrolidin-2-one
11. 1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one
12. Nsc-758223
13. 2-pyrrolidinone, 1-(4-methoxybenzoyl)-
14. Mls000079240
15. Chebi:47943
16. 5l16lkn964
17. Ro-135057
18. Ncgc00015116-10
19. Smr000038438
20. Dsstox_cid_25128
21. Dsstox_rid_80691
22. Dsstox_gsid_45128
23. Aniracetamun
24. Memodrin
25. 1-anisoyl-2-pyrrolidinone
26. Aniracetamun [inn-latin]
27. Aniracetam [usan:inn:jan]
28. Cas-72432-10-1
29. Sr-01000003147
30. Ro 135057
31. Brn 4807205
32. Reset
33. Unii-5l16lkn964
34. 1-(p-methoxybenzoyl)-2-pyrrolidinon [german]
35. Aniracetam ,(s)
36. 1-(p-methoxybenzoyl)-2-pyrrolidinon
37. Mfcd00153767
38. Spectrum_001342
39. Tocris-0867
40. Aniracetam, >=98%
41. Aniracetam [mi]
42. Opera_id_294
43. Aniracetam [inn]
44. Aniracetam [jan]
45. Spectrum3_001553
46. Spectrum4_000761
47. Spectrum5_001609
48. Aniracetam [usan]
49. Lopac-a-9950
50. Biomol-nt_000222
51. Aniracetam [mart.]
52. Aniracetam [who-dd]
53. Lopac0_000115
54. Schembl70998
55. Bspbio_003026
56. Kbiogr_001142
57. Kbioss_001822
58. Mls000028591
59. Mls001201800
60. Aniracetam (jan/usan/inn)
61. Chembl36994
62. Divk1c_000403
63. Spectrum1503078
64. Bpbio1_001316
65. Gtpl4133
66. Dtxsid5045128
67. Hms501e05
68. Kbio1_000403
69. Kbio2_001822
70. Kbio2_004390
71. Kbio2_006958
72. Kbio3_002526
73. Zinc15951
74. Ninds_000403
75. Bcpp000399
76. Hms2089o17
77. Hms2094k07
78. Hms2234e11
79. Hms3260g12
80. Hms3266l08
81. Hms3411p17
82. Hms3657g11
83. Hms3675p17
84. Hms3713n20
85. Hms3884c09
86. Pharmakon1600-01503078
87. Bcp02091
88. Tox21_110086
89. Tox21_500115
90. 1-(4-methoxybenzoyl)-2-pyrrolidone
91. Nsc758223
92. S1281
93. 1-(p-methoxybenzoyl)-2-pyrrolidinone
94. Akos005066313
95. Tox21_110086_1
96. Ab04115
97. Bcp9000303
98. Ccg-204210
99. Cs-1793
100. Db04599
101. Ks-5313
102. Lp00115
103. Nsc 758223
104. Sdccgsbi-0050103.p005
105. Idi1_000403
106. Aniracetam;p-methoxybenzoyl-2-pirrolidone
107. Ncgc00015116-01
108. Ncgc00015116-02
109. Ncgc00015116-03
110. Ncgc00015116-04
111. Ncgc00015116-05
112. Ncgc00015116-06
113. Ncgc00015116-07
114. Ncgc00015116-08
115. Ncgc00015116-09
116. Ncgc00015116-11
117. Ncgc00015116-12
118. Ncgc00015116-13
119. Ncgc00015116-24
120. Ncgc00021402-02
121. Ncgc00021402-05
122. Ncgc00021402-06
123. Ncgc00021402-07
124. Ncgc00021402-08
125. Ncgc00260800-01
126. Ro-13-3057
127. 1-(4-methoxy-benzoyl)-pyrrolidin-2-one
128. 1-(4-methoxybenzoyl)-2-pyrrolidinone #
129. Ac-15651
130. Aniracetam P-methoxybenzoyl-2-pirrolidone
131. Ba164183
132. Hy-10932
133. Sbi-0050103.p004
134. Eu-0100115
135. Ft-0649064
136. Sw199095-2
137. A 9950
138. D01883
139. H10883
140. Ab00053303-14
141. Ab00053303_15
142. Ab00053303_16
143. Aniracetam; 1-p-anisoyl-2-pyrrolidinone
144. 432a101
145. A837527
146. Q417630
147. Sr-01000003147-2
148. Sr-01000003147-4
149. Sr-01000003147-6
150. Sr-01000003147-8
151. Brd-k88611939-001-02-6
152. Brd-k88611939-001-13-3
Molecular Weight | 219.24 g/mol |
---|---|
Molecular Formula | C12H13NO3 |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 219.08954328 g/mol |
Monoisotopic Mass | 219.08954328 g/mol |
Topological Polar Surface Area | 46.6 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 282 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Aniracetam possesses a wide range of anxiolytic properties, which may be mediated by an interaction between cholinergic, dopaminergic and serotonergic systems.
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX11 - Aniracetam
1-2.5 hours
Global Sales Information
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?